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Open access under CC BY license.Theactivationofantigenreceptorstriggerstwoimportant
signalling pathways originating from phosphatidylinosi-
tol(4,5)-bisphosphate [PtdIns(4,5)P2].Thefirst isphospho-
lipase Cg (PLCg)-mediated hydrolysis of PtdIns(4,5)P2,
resulting in the activation of Ras, protein kinase C and
Ca2+ flux. This culminates in profound alterations in
gene expression and effector-cell responses, including
secretory granule exocytosis and cytokine production.
By contrast, phosphoinositide 3-kinases (PI3Ks) phos-
phorylate PtdIns(4,5)P2 to yield phosphatidylinositol
(3,4,5)-trisphosphate, activating signalling pathways that
overlapwith PLCg or are PI3K-specific. Pathways that are
PI3K-specific include Akt-mediated inactivation of Foxo
transcription factors and transcription-independent regu-
lation of glucose uptake and metabolism. The p110d iso-
form of PI3K is the main source of PI3K activity following
antigen recognitionbyB cells, T cells andmast cells. Here,
we review the roles of p110d in regulating antigen-depen-
dent responses in these cell types.
Introduction
Leukocytes express a repertoire of receptors to recognize
and bind to extracellular antigen. This binding can be
direct, as in the case of the B-cell antigen receptor
(BCR) and the T-cell antigen receptor (TCR), or indirect,
namely through receptors that interact with the Fc portion
of immunoglobulins (Ig). The latter include the high affi-
nity receptor for IgE (termed FceRI) on mast cells and
basophils, and the FcgR for IgG on phagocytes, NK cells
and B cells. PI3K activity has been implicated in the
signalling of all types of antigen receptors.
PI3K isoforms
Mammals have eight isoforms of phosphoinositide 3-kinase
(PI3K), divided into three classes [1]. Class IA PI3Ks signal
downstream of tyrosine kinases and Ras [1]. Class IA p110
catalytic subunits (p110a, p110b and p110d) are constitu-
tively bound to an SH2 domain-containing adaptor protein,
of which there are five species in mammals (p85a, p55a,
p50a, p85b and p55g; often referred to as ‘p85s’). None of theCorresponding authors: Okkenhaug, K. (klaus.okkenhaug@bbsrc.ac.uk);
Vanhaesebroeck, B. (bartvanh@ludwig.ucl.ac.uk).
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and, in vitro, each p85 can interact with each p110 species.
The Src homology 2 (SH2) domains of p85s are thought to
bind preferentially to tyrosine (Tyr)-based motifs known as
YpxxM (Yp, phosphoTyr;M,methionine; x, any amino acid).
The p110g PI3K, which belongs to the class IB subset of
PI3Ks, also phosphorylates phosphatidylinositol(4,5)-
bisphosphate [PtdIns(4,5)P2] but is activated by G
protein-coupled receptors (GPCRs) instead of through tyro-
sine kinases. p110g is also regulated by Ras [2]. In immune
cells, p110g is activated mainly by chemokines and by
adenosine [3–5]. Therefore, p110g might generate a dis-
tinct pool of phosphatidylinositol (3,4,5)-trisphosphate
[PtdIns(3,4,5)P3] in activated cells.
The class II and class III PI3Ks have not been implicated
in immune signalling, and are not considered further here.
PI3K isoforms and antigen receptor signalling
Of the three class IA PI3K catalytic isoforms (p110a, p110b
and p110d), p110d seems to have evolved to regulate PI3K-
dependent processes in immune cells, most probably in
part related to its high expression in these cells compared
with most other cell types. Lymphocyte and mast-cell
antigen receptor-dependent PI3K signalling is comprom-
ised in mice in which p110d has been inactivated by gene
deletion [6,7], point mutation (p110dD910A) [8] or small-
molecule p110d inhibitors [9–11]. p110d seems to be less
crucial in IgG-based antigen receptor (FcgR)-mediated
phagocytosis in macrophages, where the p110b isoform
seems to be more important [12]. It should be noted that
p110a and p110b are also expressed in leukocytes, and
together can contribute up to 50% of the total p85-associ-
ated PI3K activity in some leukocytes [8–10,14]. Therefore,
although we emphasize the predominant role of p110d in
antigen receptor signalling in this review, it is possible that
roles for p110a and p110b in this signalling context will be
uncovered with the ongoing development of conditional
knockout mice and selective inhibitors for these PI3K
isoforms.Conversion of PtdIns(4,5)P2 downstream of antigen
receptors
Antigen receptor stimulation initiates the activation
of Src and Syk family Tyr kinases, resulting in Tyr06.12.007
Figure 1. Metabolism of PtdIns(4,5)P2 by PLCg and PI3K. PLCg hydrolyses PtdIns(4,5)P2 to yield Ins(1,4,5)P3 and DAG, both of which function as signalling molecules.
Ins(1,4,5)P3 stimulates the release of Ca
2+ from the ER into the cytosol, which triggers the nuclear translocation of NFAT. DAG binds to and activates RasGRP, which
stimulates Ras and the Erk pathway, leading to AP-1-dependent transcription. Ras also binds to p110 and contributes to optimal PI3K activation. DAG binds to and activates
PKC, which activates NF-kB through CARMA1, BCL10 and MALT1. By contrast, PI3K phosphorylates PtdIns(4,5)P2 at position 3 to produce the membrane phosphoinositol
lipid PtdIns(3,4,5)P3. PtdIns(3,4,5)P3 functions as an anchor and cofactor for proteins with PtdIns(3,4,5)P3-binding PH domains such as Akt, Tec family kinases, and various
GEFs and GAPs. Pdk1 is required to co-activate Akt. Akt phosphorylates and inactivates Foxo and GSK3. GSK3 can phosphorylate and inactivate NFAT. Akt stimulates mTOR
through Tsc1 and Tsc2. Tec kinases can phosphorylate PLCg and contribute to its optimal activity. PI3K signalling is antagonised by the Pten phosphoinositide phosphatase,
which removes the 3-phosphate, and the SHIP phosphatase, which removes the 5-phosphate. The role of PI(3,4)P2-binding proteins is still unknown. Although PLCg and
PI3K generate mutually exclusive second messenger signalling molecules, several of the pathways activated by these second messengers interact, and the signals are
further integrated by the cell to promote gene transcription, cell growth and differentiation. p110d seems to be the principal PI3K isoform in the context of antigen receptor
signaling; however, p110a and p110b are also expressed in lymphocytes but their roles in antigen receptor signalling are unknown. Abbreviations: BCL10, B cell lymphoma
10; CARMA1, caspase recruitment domain (CARD)-containing membrane-associated guanylate kinase (MAGUK) protein 1; IP3, inositol(1,4,5)-trisphosphate; MALT1,
mucosa-associated lymphoid tissue lymphoma translocation protein 1; PI, phosphatidylinositol.
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two PtdIns(4,5)P2-based signalling pathways (Figure 1).
The first of these is mediated by phospholipase C
(PLC)g, which hydrolyses PtdIns(4,5)P2 to generate
diacylglycerol (DAG) and inositol(1,4,5)-trisphosphate
[Ins(1,4,5)P3] (Figure 1). The water-soluble Ins(1,4,5)P3
triggers a biphasic Ca2+ response, initially by inducing
Ca2+ release from the endoplasmic reticulum, followed by
Ca2+-dependent opening of plasmamembrane channels to
enable sustainedCa2+ influxand thenuclear translocation
of NFAT (nuclear factor of activated T cells) transcription
factors [15]. DAG activates Ras guanyl nucleotide-releas-
ing proteins (RasGRPs, which bind to Ca2+ and DAG) and
isoforms of protein kinase C (PKC), which initiate the
Ras–Erk–AP-1 and nuclear factor (NF)-kB signalling
pathways, respectively [16–20]. Hence, the hydrolysis of
PtdIns(4,5)P2 by PLCg is sufficient to initiate the acti-
vation of three transcription factor families (Figure 1) that
coordinately regulate the expression of a vast number of
genes involved in cytokine production, cell division and
differentiation [21,22]. Antigen receptor cross-linking also
activates PLCg-dependent pathways involved in promot-
ing the release of preformed mast-cell secretory granules,
which promote the early symptoms of allergic hypersen-
sitivity reactions [19].www.sciencedirect.comClass I PI3Ks mediate an alternative conversion of
PtdIns(4,5)P2, namely by phosphorylating this lipid to
PtdIns(3,4,5)P3 (Figure 1). In contrast to its precursor,
PtdIns(3,4,5)P3 is resistant to PLC-mediated hydrolysis
and, instead, signals at the plasma membrane by func-
tioning as docking sites for pleckstrin homology (PH)
domains that are present in several proteins [1]. These
PtdIns(3,4,5)P3 targets include protein kinases (such as
Pdk1, Akt and Tec kinases), adaptor proteins (such as
Gab2), and GTPase activating proteins (GAPs) and gua-
nine nucleotide exchange factors (GEFs) for small
GTPases (such as P-Rex, ARAP, SWAT-70, IBP and
Vav) [1,23,24]. PtdIns(3,4,5)P3 binding induces the rapid
recruitment of these proteins to themembrane in response
to PI3K activation and/or alteration of their conformation
or activity [25,26]. This abundance of downstream targets
link PI3K to its well-established roles in cell cycle pro-
gression, growth, prevention of apoptosis, cell migration,
differentiation and secretory granule exocytosis.
PtdIns(3,4,5)P3 is a substrate for lipid phosphatases,
amongst which the 3-phosphatase Pten and the 5-phos-
phatase SHIP are most widely studied and have important
roles in antagonising PI3K signalling [27,28]. SHIP con-
verts PtdIns(3,4,5)P3 to PtdIns(3,4)P2, which can bind to a
limited set of PH domains, including those of tandem PH
82 Review TRENDS in Immunology Vol.28 No.2domain-containing protein (TAPP)1 and TAPP2 [29]
(Figure 1).
PI3K coupling to the antigen receptor
The details of how PI3Ks are linked to antigen
receptor-associated signalling complexes are still vague
[30–32]. What is clear is that PtdIns(3,4,5)P3 accumulation
occurs extremely rapidly following antigen recognition,
which suggests that the association between the antigen
receptor signalling complexes and PI3K is tightly coupled
to the initial tyrosine kinase signals [29,33–38]. Several of
the adaptor molecules in the antigen receptor complex
contain canonical YxxM motifs, although the role of some
of these, including B-cell adaptor protein (BCAP) and T-cell
receptor interacting molecule (TRIM), is still unclear
[39,40] (Figure 2). An intriguing recent study suggested
that p85 can bind to Syk and zeta-chain associated protein
kinase of 70 kDa (ZAP-70) directly through non-canonical
Tyr-based motifs [41]. There is also evidence that p85 can
bind to SH2 domain-containing leukocyte phosphoprotein
of 76 kD (SLP76), again through noncanonical motifs [42].
The SH3 domains and proline-rich regions present in p85s
also offer scope for phosphorylation-independent binding
to signalling proteins. If these interactions can be con-
firmed under physiologically relevant conditions, then
we might need to cast the net wider in considering poten-
tial players in the recruitment of p85–p110 heterodimers
to antigen receptor signalling complexes.
Given that p85 species seem to have no binding
preference for specific p110 PI3K isoforms, it is anticip-
ated that this type of recruitment would not favour p110d
over p110a and p110b for association with the antigen
receptor. However, in addition to binding to p85, the p110
subunits can also bind to Ras-GTP [1]. Ras signalling is
important in antigen receptor signalling [16]. Evidence is
accumulating that each p110 isoform has a distinct bind-
ing capacity to Ras, or shows a binding preference for
specific Ras isoforms (reviewed in Ref. [1]). In one study,
p110a was found to become activated by most Ras iso-
forms, whereas p110d became activated selectively by R-
Ras andTc21; p110bdid not becomeactivated byRas at all
[43]. Hence, the differential usage of Ras isoforms could
contribute to selective recruitment and/or activation of
class IAPI3K isoforms. Therefore, the potential role of Ras
in regulating the activity of different PI3K isoforms in the
context of antigen receptor signalling warrants further
investigation.
p110d in B-cell development and function
p110d deficiencyy does not have amajor impact on the early
development of B cells in the bone marrow [6–8]. By
contrast, the development of mature B cells in the spleen
and in pleural cavities is strongly affected. Thus, the
number of follicular B2 cells is reduced to <50% of normal
numbers. In addition, the development of peritoneal B1
cells and marginal-zone B cells is almost completely
blocked [30,31,44].y We have previously commented on the relative merits of different gene-targeting
strategies [13] and in this review, we will refer collectively to p110d/ and p110dD910A/
D910A mice as p110d-deficient.
www.sciencedirect.comThe in vitro proliferation of B cells triggered by
antibody-mediated crosslinking (through anti-IgM) of the
BCR crucially depends on p110d activity [6–9]. Deletion or
inactivation of p110d or p85a largely ablates BCR-induced
phosphorylation of Akt, Foxo and protein kinase D, and
results in reduced Ca2+ flux, impaired cell cycle pro-
gression and reduced glucose metabolism [9,45–50]. Inter-
leukin (IL)-4-dependent survival is also compromised in
the absence of p110d activity [9]. CD40 and lipopolysac-
charide signalling is less dependent on PI3K signalling, so
activated T cells and selected pathogens might still stimu-
late B-cell responses even in the context of strongly atte-
nuated BCR signalling [8,51]. PI3K had initially been
suggested to be part of a BCR-associated signalosome
based on the similar phenotypes of Btk, p85a, p110d,
and PLCg knockout mice. In this model, the principal role
for PI3K would be to promote PLCg activity [52]. Although
the role of PI3K in regulating PLCg is well established,
recent evidence shows that PLCg and PI3K pathways also
function in parallel (Figure 1). Thus, p85a–Btk and p85a–
PLC-g2 double-knockout mice show much more dramatic
phenotypes than any of the single knockout mice and
provide evidence for PLCg-independent functions for
PI3K [53,54].
PI3K activation in B cells can be enhanced by the
coordinated engagement of the BCR and its co-receptor
CD19, which contains YxxM recruitment motifs for PI3K
[55]. This enables added sensitivity of the B cells to anti-
gens that are coated with complement. In this context, Vav
is required for optimal PI3K responses, perhaps reflecting
a role for Vav in coordinating crosstalk between these
receptors by assembling larger signalling complexes
[56,57]. The B-cell phenotypes observed in p85a-knockout
and p110d-deficient mice largely overlap with those
observed in CD19-deficient mice. The key role for PI3K
in the context of CD19 function is further evidenced by the
failure to rescue a normal B-cell phenotype in CD19 knock-
out mice by the transgenic expression of a CD19 mutant
that cannot bind to PI3K [58]. Moreover, Pten-deficiency
can partially revert the effect of CD19 deficiency, presum-
ably by lowering the signalling threshold required to
initiate PI3K signalling [59]. Co-ligation of the BCR and
FcgRIIB, a low affinity receptor for IgG, also forms the
basis for modulating PtdIns(3,4,5)P3 signals downstream
of the BCR through the recruitment of SHIP, which
converts PtdIns(3,4,5)P3 into PtdIns(3,4)P2, thereby inhi-
biting BCR responses [60].
Antigen challenge triggers a primary humoral immune
response that is characterized by clonal expansion and B-
cell differentiation into IgM-secreting plasma cells. Alter-
natively, B cells can be recruited into the T-cell-rich areas of
the splenic follicles, where the Ig loci undergo class-switch
recombination (CSR) and somatic hypermutation leading to
the production of higher affinity antibodies of the IgG or IgE
subclasses. Immunized p110d-deficient mice show reduced
germinal centre (GC) formation and impaired T-cell-depen-
dent and T-cell-independent immune responses, suggesting
a positive role for p110d in the GC reactions [6,8]. However,
there is also evidence for a negative role of p110d in the
GC reaction: Pten-deficient B cells fail to induce activation-
induced cytidine deaminase, an essential regulator of CSR
Figure 2. Antigen receptor complexes and p110d antigen receptor signalling in different cell types has key commonalities, the most crucial of which is the phosphorylation
of ITAM motifs found in proteins that are noncovalently associated with the polypeptides that bind to the antigen or antibody–antigen complexes. Src-family kinases
phosphorylate these ITAMmotifs, thus providing docking sites for Syk kinases. Syk kinases phosphorylate PLCg, resulting in its activation, in addition to the recruitment of
various cellular and membrane-bound adaptor proteins, such as LAT, Gab2, SLP-76 (in T cells and mast cells) and SLP-65 (in B cells) that nucleate larger signalling
complexes [18,19]. The upstream activators of PI3K in the context of antigen receptor signalling have not been definitively defined, and possible links with the SH2 domains
of p85 are indicated by dashed arrows. Phosphorylation-independent interactions of PI3K with upstream signalling molecules are not shown. Note that the antigens are
shown as monomers for illustrative purposes. In reality, dimers or oligomers of the ligands and receptors are required to trigger the signalling cascades shown. (a) BCR
signalling. Lyn-dependent phosphorylation of Iga and Igb ITAM motifs results in the recruitment of Syk and the phosphorylation of SLP-65. Several proteins in the BCR
receptor complex have been implicated in binding to p85. BCAP is a transmembrane adaptor protein with YxxM motifs which becomes phosphorylated by Syk upon BCR
activation. BCAP has been shown to regulate PI3K signalling in DT40 chicken cells but was found to be not required for PI3K signalling in primary mouse B cells [40,87].
Similarly, Vav had been proposed to lie upstream of PI3K signalling [56]; however, BCR crosslinking of primary Vav-deficient B cells results in normal Akt phosphorylation
(although Akt phosphorylation in response to BCR and CD19 coligation was Vav-dependent) [51]. Other candidates that link PI3K to the activated BCR include Gab1, non
T-cell activation linker (NTAL) and LAT. However, many of these interactions have only been identified in cell lines, and in several cases, their roles in PI3K signalling
downstream of the BCR have not been confirmed in mice [88,89]. (b) TCR signalling. Lck and Fyn phosphorylate ITAM motifs resulting in the recruitment of ZAP-70, which
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84 Review TRENDS in Immunology Vol.28 No.2[61]. Moreover, Akt phosphorylation and the inactivation of
Foxo proteins by p110dwas shown to suppress CSR, favour-
ing the formation of IgM-secreting antibody effectors [62].
How these results correlate with the diminished IgG-
mediated responses in p110d-deficient mice is unclear.
Onepossibility is thatp110d-deficientT cells cannot support
full GC reactions. In addition, an earlier developmental
lesion in p110d-deficient B cells might reduce dramatically
the number of B cells poised for participation in the GC
reaction. Therefore, although p110d has a positive role in
mitogenic signalling through the BCR, p110d might also
negatively regulate differentiation programmes that lead to
CSR and secondary immune responses.
p110d in T-cell development and function
T-cell development in the thymus progresses through three
checkpoints: b-selection, where CD4–CD8– double-nega-
tive T cells are examined for pre-TCRb expression; positive
selection, where CD4+CD8+double-positive TCRab+ T cells
are selected to become CD4+ or CD8+ single-positive T
cells; and negative selection, where autoreactive T cells
are eliminated.
PtdIns(3,4,5)P3 signalling is both sufficient and
necessary for b-selection. Lck–Cre-mediated conditional
deletion of Pten in the T-cell lineage enables the develop-
ment of double-positive thymocytes in the absence of
pre-TCR expression [63,64]. Similarly, in the presence of
artificially high expression of its ligand CD86, CD28 can
promote the development of double-positive T cells in the
absence of pre-TCR, but only if the PI3K-binding motif is
intact [65].
b-selection seems normal in p110d-deficient mice [8,66],
suggesting the involvement of other class I PI3Ks. One of
these might be p110g, as T cells lacking this PI3K have a
partial defect at this selection stage, resulting in a reduced
number of double-positive T cells [4]. p110g/ p110d/
double-knockout mice have a profound block at the
pre-TCR selection step, with a dramatic reduction of
double-positive cells [66,67]. This is a surprising obser-
vation, given that GPCRs have not previously been shown
to be required at this selection step. It is presently unclear
whether there is a chemokine receptor or another GPCR
that functions in concert with the pre-TCR at this stage, or
whether p110g can be activated by non-GPCR receptors.
Positive selection is unaffected in p110d-deficient thymo-
cytes; however, negative selection of autoreactive T cells is
partially impaired [68].
In peripheral T cells, PI3Ks can be activated by the TCR,
by costimulatory receptors such as CD28 and ICOS, and by
receptors for cytokines and chemokines [30,69]. p110d
seems to be the main PI3K isoform that generates
PtdIns(3,4,5)P3downstreamof theTCRandCD28, although
p110aand/or p110bare also likely to contribute [8,14,70]. In(Figure 2 Legend Continued) phosphorylates LAT. TRIM is a transmembrane adaptor p
However, TRIM knockout mice show enhanced instead of impaired Akt phosphorylat
Although the exact biochemical link between Vav and PI3K is not clearly defined, it may
can bind to the SH2 domains of p85 directly; however, CD28 can provide potent costim
Lyn phosphorylates ITAMmotifs in the b and g chains of the FceRI resulting in the recruit
through GAB2–PI3K and LAT–PLCg. The link shown between NTAL and GAB2 is h
degranulation. (d) Chemokine receptor signalling. The p110g heterodimer binds to the
chemokines. Despite the potent activation of p110g by chemokines, p110g seems to h
promote the survival of developing thymocytes and memory T cells [92].
www.sciencedirect.comthe immune synapse, PtdIns(3,4,5)P3 accumulation is
observed as one of the earliest traceable signals and is
sustained for hours, as long as the conjugate formation
between antigen-presenting cells and T cells is maintained
[33–35]. The relative contributions made by the TCR and
CD28 to PI3K activity in the synapse are still unknown;
however, synapse accumulation can occur under conditions
where CD28 costimulation is absent [33,37]. A key effect of
PI3K signalling in T cells is the activation of Akt, which
phosphorylates Foxo transcription factors that then become
excluded from the nucleus [14,38,71]. In addition, Akt can
contribute to glycolysis and protein synthesis; however,
PI3K-independent pathways can also contribute to at least
some of these effects [38,72–74].
In T cells with inactive p110d, defects in proliferation
and cytokine secretion were most clearly revealed when
TCR-transgenic T cells were stimulated with cognate anti-
gen [8,14]. In particular, T-helper (Th)1 and Th2 cytokine
production was reduced dramatically [14]. As a con-
sequence of reduced Th2 responses, p110-deficient mice
were protected from experimentally induced airway
inflammation [75]. In vitro, the reduction in Th1 and
Th2 cytokine production could not be rescued by providing
an excess of exogenous cytokines and was still defective
among T cells that had undergone several rounds of
division [14]. Therefore, there seems to be a block in the
genetic programme that enables T cells to open the IL-4 or
interferon (IFN)g gene loci. We hypothesize that this block
reflects the capacity of PI3Ks to relieve T cells from the
blocks imposed by transcription factors of the Foxo family.
Unless the suppression by Foxo transcription factors is
lifted by PI3K activation, the cell is unable to differentiate
further. In this scenario, PI3Ks and, more specifically,
p110d, function in parallel to the canonical TCR signalling
pathway initiated by PLCg (Figure 1). That is, initial
activation events that lead to clonal expansion and IL-2
secretion do occur but further differentiation is blocked.
Consistent with this notion, mice that lack Foxo3a, one of
the Foxo transcription factors, suffer from exaggerated
Th1 and Th2 responses and autoimmune syndromes [76].
A third lineage of CD4+ T cells, referred to as regulatory
T (Treg) cells, restrict the expansion and function of Th
cells [77]. Mice that lack Treg cells die young as a con-
sequence of T cell-mediated multi-organ destruction. Mice
that have partial defects in Treg-cell development tend to
develop colitis as Treg cells have a key role in suppressing
immune responses against the gut flora [78]. p110d-
deficient mice also show subclinical signs of colitis as
detected by histological examination [8]. Moreover,
p110d-deficient Treg cells show attenuated capacity to
suppress Th cells in vitro and fail to protect against exper-
imentally induced colitis in vivo [68]. Interestingly, p85b
knockout mice with T-cell-specific deletion of p85a haverotein that associates with the TCR and becomes phosphorylated on YxxM motifs.
ion [39]. Vav has an important role in regulating Akt and Foxo phosphorylation.
reflect a more general role for Vav in assembling LAT complexes [71,90,91]. CD28
ulatory signals independently of its association with PI3K [30]. (c) FceRI signalling.
ment of Syk, which phosphorylates GAB2 and LAT, inducing two parallel pathways
ypothetical. c-Kit can bind to p85 directly and can potentiate FceRI-stimulated
Gbg subunit released from Ga following GPCR stimulation with agonists such as
ave a minor role in promoting lymphocyte chemotaxis [3]. Instead, p110g might
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develop an autoimmune disease that is reminiscent of
Sjo¨gren’s syndrome [79]. The latter experiments also
demonstrated that although p85a-deficiency is sufficient
to suppress PI3K signalling in B cells, both p85a and p85b
need to be deleted to uncover a PI3K-deficient phenotype in
T cells [93].
p110d in mast cell development and function
Mast cells are amongst a select group of cells (including
basophils and eosinophils) that express the FceRI
(Figure 2). Antigen-specific IgE from the plasma binds to
FceRI with high affinity, enabling the mast cells to partici-
pate in the adaptive immune response. Antigen-induced
aggregation of FceRI-bound IgE activates a series of
intracellular signalling events, culminating in secretory-
granule exocytosis and the release of pro-inflammatory
mediators that promote the allergic cascade [19].
The activation of FceRI triggers a tyrosine kinase
cascade involving Lyn, Fyn and Syk, resulting in the
activation of the linker for activation of T cells (LAT)–
PLCg and GRB2-associated binding protein 2 (GAB2)–
PI3K pathways (Figure 2) [19]. These pathways recruit
PI3K and interact with effectors that drive Ca2+ mobiliz-
ation and PKC activation, which are both a prerequisite for
mast-cell exocytosis [80].
Pan-PI3K inhibitors can attenuate IgE–antigen-
dependent secretory-granule exocytosis severely [81].
Conversely, genetic interference with SHIP and Pten
enhances FceRI responses [82,83]. Akt might control
IL-2 and TNF-a production by regulating NF-kB [84].
Two other potential PI3K effectors downstream of FceRI
in mast cells are Btk and phospholipase D1 (PLD1), which
both influence Ca2+ mobilization and PKC activation
strongly. Btk enhances the activities of PLCg and PKCb1
(the latter directly, or indirectly through the regulation of
PLCg) [19]. Deletion or mutation of the Btk PH domain (as
observed in Xid mice) results in reduced FceRI-dependent
Ca2+ signalling, degranulation and cytokine release [19].
PLD1 contains a PtdIns(3,4,5)P3-interacting PX domain
[85], and its activation leads to the production of phospha-
tidic acid, which is metabolized further into an important
source of DAG that can activate PKC andmight provide an
additional link between the PI3K and the PLCg pathway
in augmenting the PKC activation [86].
Most PI3K-dependent activity downstream of the FceRI
is mediated by p110d, and antigen receptor-induced Akt
activation is almost completely eliminated following p110d
inactivation [10]. Mast cells derived from p110d-deficient
mice, or wild-type mast cells treated with a p110d-selective
inhibitor, have a substantial reduction in IgE–antigen-
dependent exocytosis and release of the pro-inflammatory
cytokines TNF-a and IL-6 [10].
Another important pathway for regulating mast-cell
proliferation, migration and adhesion is through the c-
kit receptor Tyr kinase, which is activated by the SCF
ligand. c-kit has a YxxM motif that can recruit p85–p110
complexes. Interestingly, similar to the FceRI, PI3K-
dependent responses downstream of the c-kit receptor
are almost completely p110d-dependent [10]. Allergic
responses occur in an SCF-rich environment, whichwww.sciencedirect.compotentiates FceRI responses. The observation that both
the FceRI and its key modulating receptor c-kit depend
heavily on p110d activity is an important rationale for
developing p110d inhibitors for allergy indications [10].
Indeed, inactivating p110d in mice results in a substantial
reduction in the allergic response [10,11]. However, a
residual PI3K-dependent allergic response is observed in
p110d-deficient mast cells and mice [10]. The identity of
this PI3K(s) is still elusive and could either be another
class 1A PI3K isoform or it could be p110g. Indeed, GPCR-
coupled p110g is thought to operate downstream of
activated FceRI through a GPCR-dependent autocrine or
paracrine amplification mechanism [5].
Concluding remarks
p110d seems to have evolved as the main source of
PtdIns(3,4,5)P3 production following antigen recognition
by B cells, T cells and mast cells. Although the p110a and
p110b isoforms might also contribute to antigen receptor
signalling, their contributions seem less important than
those of p110d, for reasons that are not understood. In
this respect, the role of p110d is unique: its attenuation
affects antigen receptor signalling in B cells, T cells and
mast cells, yet p110d is dispensable for the function of
most tissues and organs. No other kinase associated with
the antigen receptor signalling machinery shares this
profile. Instead, the expression of Src, Syk and Tec family
kinase isoforms differs between B cells, T cells and mast
cells. Hence, p110d presents a unique opportunity to
modulate antigen receptor signalling using small-mol-
ecule inhibitors.
It will also be important to investigate the contribution
of each of the four class I PI3K isoforms to signalling by
other immune receptors. This should be facilitated through
the availability of a range of PI3K gene-targeted mice and
PI3K isoform-selective inhibitors that are now becoming
available. These studies should pave the way towards the
clinical development of small-molecule inhibitors against
PI3K isoforms, in particular p110d, which could alleviate
harmful immune responses against self antigens, trans-
plantation antigens and innocuous foreign antigens in
allergy.
Acknowledgements
We thank Elena Vigorito and Robert Salmond for critical reading of the
manuscript. K.O. is supported by a BBSRC David Phillips Fellowship.
K.A. is supported by the Biotechnology and Biological Science Research
Council, UK (grant BB/C505659/1). Work in B.V.’s laboratory is
supported by the Ludwig Institute for Cancer Research and the
European Union MAIN consortium (FP6–502935).
References
1 Vanhaesebroeck, B. et al. (2001) Synthesis and function of 3-
phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535–602
2 Suire, S. et al. (2006) Gbgs and the Ras binding domain of p110g are
both important regulators of PI3Kg signalling in neutrophils.Nat. Cell
Biol. 8, 1303–1309
3 Ward, S.G. (2006) T lymphocytes on the move: chemokines, PI 3-kinase
and beyond. Trends Immunol. 27, 80–87
4 Sasaki, T. et al. (2000) Function of PI3Kg in thymocyte development,
T cell activation, and neutrophil migration. Science 287, 1040–
1046
5 Laffargue, M. et al. (2002) Phosphoinositide 3-kinase g is an essential
amplifier of mast cell function. Immunity 16, 441–451
86 Review TRENDS in Immunology Vol.28 No.26 Clayton, E. et al. (2002) A crucial role for the p110d subunit of
phosphatidylinositol 3-kinase in B cell development and activation.
J. Exp. Med. 196, 753–763
7 Jou, S.T. et al. (2002) Essential, nonredundant role for the
phosphoinositide 3-kinase p110d in signaling by the B-cell receptor
complex. Mol. Cell. Biol. 22, 8580–8591
8 Okkenhaug, K. et al. (2002) Impaired B and T cell antigen receptor
signaling in p110d PI 3-kinase mutant mice. Science 297, 1031–1034
9 Bilancio, A. et al. (2006) Key role of the p110d isoform of PI3K in B-cell
antigen and IL-4 receptor signaling: comparative analysis of genetic
and pharmacologic interference with p110d function in B cells. Blood
107, 642–650
10 Ali, K. et al. (2004) Essential role for the p110d phosphoinositide 3-
kinase in the allergic response. Nature 431, 1007–1011
11 Lee, K.S. et al. (2006) Inhibition of phosphoinositide 3-kinase d
attenuates allergic airway inflammation and hyperresponsiveness in
murine asthma model. FASEB J. 20, 455–465
12 Leverrier, Y. et al. (2003) Class I phosphoinositide 3-kinase p110b is
required for apoptotic cell and Fcg receptor-mediated phagocytosis by
macrophages. J. Biol. Chem. 278, 38437–38442
13 Vanhaesebroeck, B. et al. (2005) Signalling by PI3K isoforms: insights
from gene-targeted mice. Trends Biochem. Sci. 30, 194–204
14 Okkenhaug, K. et al. (2006) The p110d isoform of phosphoinositide 3-
kinase controls clonal expansion and differentiation of Th cells. J.
Immunol. 177, 5122–5128
15 Gallo, E.M. et al. (2006) Lymphocyte calcium signaling frommembrane
to nucleus. Nat. Immunol. 7, 25–32
16 Samelson, L.E. (2002) Signal transduction mediated by the T cell
antigen receptor: the role of adapter proteins. Annu. Rev. Immunol.
20, 371–394
17 Niiro, H. and Clark, E.A. (2002) Decision making in the immune
system: regulation of B-cell fate by antigen-receptor signals. Nat.
Rev. Immunol. 2, 945–956
18 Koretzky, G.A. et al. (2006) SLP76 and SLP65: complex regulation of
signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6, 67–78
19 Gilfillan, A.M. and Tkaczyk, C. (2006) Integrated signalling pathways
for mast-cell activation. Nat. Rev. Immunol. 6, 218–230
20 Thome, M. (2004) CARMA1, BCL-10 and MALT1 in lymphocyte
development and activation. Nat. Rev. Immunol. 4, 348–359
21 Diehn, M. et al. (2002) Genomic expression programs and the
integration of the CD28 costimulatory signal in T cell activation.
Proc. Natl. Acad. Sci. U. S. A. 99, 11796–11801
22 Riley, J.L. et al. (2002) Modulation of TCR-induced transcriptional
profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl.
Acad. Sci. U. S. A. 99, 11790–11795
23 Welch, H.C. et al. (2003) Phosphoinositide 3-kinase-dependent
activation of Rac. FEBS Lett. 546, 93–97
24 Vanhaesebroeck, B. and Alessi, D.R. (2000) The PI3K–PDK1
connection: more than just a road to PKB. Biochem. J. 346, 561–576
25 Milburn, C.C. et al. (2003) Binding of phosphatidylinositol 3,4,5-
trisphosphate to the pleckstrin homology domain of protein kinase
B induces a conformational change. Biochem. J. 375, 531–538
26 Lemmon, M.A. and Ferguson, K.M. (2000) Signal-dependent
membrane targeting by pleckstrin homology (PH) domains.
Biochem. J. 350, 1–18
27 Krystal, G. (2000) Lipid phosphatases in the immune system. Semin.
Immunol. 12, 397–403
28 Sasaki, T. et al. (2002) Phosphoinositide 3-kinases in immunity: lessons
from knockout mice. J. Biochem. (Tokyo) 131, 495–501
29 Krahn, A.K. et al. (2004) Two distinct waves of membrane-proximal B
cell antigen receptor signaling differentially regulated by Src homology
2-containing inositol polyphosphate 5-phosphatase. J. Immunol. 172,
331–339
30 Okkenhaug, K. and Vanhaesebroeck, B. (2003) PI3K in lymphocyte
development, differentiation and activation. Nat. Rev. Immunol. 3,
317–330
31 Deane, J.A. and Fruman, D.A. (2004) Phosphoinositide 3-kinase:
diverse roles in immune cell activation. Annu. Rev. Immunol. 22,
563–598
32 Koyasu, S. (2003) The role of PI3K in immune cells. Nat. Immunol. 4,
313–319
33 Harriague, J. and Bismuth, G. (2002) Imaging antigen-induced PI3K
activation in T cells. Nat. Immunol. 3, 1090–1096www.sciencedirect.com34 Costello, P.S. et al. (2002) Sustained and dynamic inositol lipid
metabolism inside and outside the immunological synapse. Nat.
Immunol. 3, 1082–1089
35 Huppa, J.B. et al. (2003) Continuous T cell receptor signaling required
for synapse maintenance and full effector potential. Nat. Immunol. 4,
749–755
36 Astoul, E. et al. (1999) The dynamics of protein kinase B regulation
during B cell antigen receptor engagement. J. Cell Biol. 145, 1511–
1520
37 Kane, L.P. et al. (2004) A proline-rich motif in the C terminus of Akt
contributes to its localization in the immunological synapse. J.
Immunol. 172, 5441–5449
38 Fabre, S. et al. (2005) Stable activation of phosphatidylinositol 3-kinase
in the T cell immunological synapse stimulates Akt signaling to FoxO1
nuclear exclusion and cell growth control. J. Immunol. 174, 4161–4171
39 Kolsch, U. et al. (2006) Normal T-cell development and immune
functions in TRIM-deficient mice. Mol. Cell. Biol. 26, 3639–3648
40 Yamazaki, T. et al. (2002) Essential immunoregulatory role for BCAP
in B cell development and function. J. Exp. Med. 195, 535–545
41 Moon, K.D. et al. (2005)Molecular basis for a direct interaction between
the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J. Biol.
Chem. 280, 1543–1551
42 Shim, E.K. et al. (2004) Association of the Src homology 2 domain-
containing leukocyte phosphoprotein of 76 kD (SLP-76) with the p85
subunit of phosphoinositide 3-kinase. FEBS Lett. 575, 35–40
43 Rodriguez-Viciana, P. et al. (2004) Signaling specificity by Ras family
GTPases is determined by the full spectrum of effectors they regulate.
Mol. Cell. Biol. 24, 4943–4954
44 Donahue, A.C. and Fruman, D.A. (2004) PI3K signaling controls cell
fate at many points in B lymphocyte development and activation.
Semin. Cell Dev. Biol. 15, 183–197
45 Yusuf, I. et al. (2004) Optimal B-cell proliferation requires
phosphoinositide 3-kinase-dependent inactivation of FOXO
transcription factors. Blood 104, 784–787
46 Glassford, J. et al. (2005) Phosphatidylinositol 3-kinase is required for
the transcriptional activation of cyclin D2 in BCR activated primary
mouse B lymphocytes. Eur. J. Immunol. 35, 2748–2761
47 Donahue, A.C. and Fruman, D.A. (2003) Proliferation and survival of
activated B cells requires sustained antigen receptor engagement and
phosphoinositide 3-kinase activation. J. Immunol. 170, 5851–5860
48 Vigorito, E. et al. (2006) Synergistic activation of PKD by the B cell
antigen receptor and CD19 requires PI3K, Vav1 and PLCg. Cell.
Signal. 18, 1455–1460
49 Doughty, C.A. et al. (2006) Antigen receptor-mediated changes in
glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-
kinase signaling in the glycolytic control of growth. Blood 107, 4458–
4465
50 Piatelli, M.J. et al. (2004) Phosphatidylinositol 3-kinase-dependent
mitogen-activated protein/extracellular signal-regulated kinase
kinase 1/2 and NF-kB signaling pathways are required for B cell
antigen receptor-mediated cyclin D2 induction in mature B cells. J.
Immunol. 172, 2753–2762
51 Hebeis, B.J. et al. (2004) The p110d subunit of phosphoinositide 3-
kinase is required for the lipopolysaccharide response of mouse B cells.
Biochem. Soc. Trans. 32, 789–791
52 Fruman, D.A. et al. (2000) Xid-like phenotypes: a B cell signalosome
takes shape. Immunity 13, 1–3
53 Suzuki, H. et al. (2003) PI3K and Btk differentially regulate B cell
antigen receptor-mediated signal transduction. Nat. Immunol. 4, 280–
286
54 Dai, X. et al. (2006) Distinct roles of phosphoinositide-3 kinase and
phospholipase Cg2 in B-cell receptor-mediated signal transduction.
Mol. Cell. Biol. 26, 88–99
55 Del Nagro, C.J. et al. (2005) CD19 function in central and peripheral B-
cell development. Immunol. Res. 31, 119–131
56 Inabe, K. et al. (2002) Vav3 modulates B cell receptor responses by
regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195,
189–200
57 Vigorito, E. et al. (2004) Vav-dependent and vav-independent
phosphatidylinositol 3-kinase activation in murine B cells
determined by the nature of the stimulus. J. Immunol. 173, 3209–3214
58 Wang, Y. et al. (2002) The physiologic role of CD19 cytoplasmic
tyrosines. Immunity 17, 501–514
Review TRENDS in Immunology Vol.28 No.2 8759 Anzelon, A.N. et al. (2003) Pten inactivation alters peripheral B
lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4,
287–294
60 Brauweiler, A.M. and Cambier, J.C. (2003) FcgRIIB activation leads to
inhibition of signalling by independently ligated receptors. Biochem.
Soc. Trans. 31, 281–285
61 Suzuki, A. et al. (2003) Critical roles of Pten in B cell homeostasis and
immunoglobulin class switch recombination. J. Exp. Med. 197, 657–
667
62 Omori, S.A. et al. (2006) Regulation of class-switch recombination and
plasma cell differentiation by phosphatidylinositol 3-kinase signaling.
Immunity 25, 545–557
63 Suzuki, A. et al. (2001) T cell-specific loss of Pten leads to defects in
central and peripheral tolerance. Immunity 14, 523–534
64 Hagenbeek, T.J. et al. (2004) The loss of PTEN allows TCR ab lineage
thymocytes to bypass IL-7 and pre-TCR-mediated signaling. J. Exp.
Med. 200, 883–894
65 Williams, J.A. et al. (2005) Regulated costimulation in the thymus is
critical for T cell development: dysregulated CD28 costimulation can
bypass the pre-TCR checkpoint. J. Immunol. 175, 4199–4207
66 Webb, L.M. et al. (2005) Cutting edge: T cell development requires the
combined activities of the p110g and p110d catalytic isoforms of
phosphatidylinositol 3-kinase. J. Immunol. 175, 2783–2787
67 Swat, W. et al. (2006) Essential role of PI3Kd and PI3Kg in thymocyte
survival. Blood 107, 2415–2422
68 Patton, D.T. et al. (2006) Cutting edge: The phosphoinositide 3-kinase
p110d Is critical for the function of CD4+CD25+Foxp3+ regulatory T
cells. J. Immunol. 177, 6598–6602
69 Rudd, C.E. and Schneider, H. (2003) Unifying concepts in CD28, ICOS
and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3, 544–556
70 Vanhaesebroeck, B. et al. (1999) Autophosphorylation of p110d
phosphoinositide 3-kinase: a new paradigm for the regulation of
lipid kinases in vitro and in vivo. EMBO J. 18, 1292–1302
71 Charvet, C. et al. (2006) Vav1 promotes T cell cycle progression by
linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J.
Immunol. 177, 5024–5031
72 Frauwirth, K.A. et al. (2002) The CD28 signaling pathway regulates
glucose metabolism. Immunity 16, 769–777
73 Wu, L.X. et al. (2005) CD28 regulates the translation of Bcl-xL via the
phosphatidylinositol 3-kinase/mammalian target of rapamycin
pathway. J. Immunol. 174, 180–194
74 Fox, C.J. et al. (2005) The Pim kinases control rapamycin-resistant T
cell survival and activation. J. Exp. Med. 201, 259–266
75 Nashed, B.F. et al. Role of the phosphoinositide 3-kinase p110d in the
generation of type 2 cytokine responses and allergic airway
inflammation. Eur. J. Immunol. (in press)
76 Lin, L. et al. (2004) Regulation of NF-kB, Th activation, and
autoinflammation by the forkhead transcription factor Foxo3a.
Immunity 21, 203–213The ScienceDire
ScienceDirect’s extensive and unique full-text colle
titles such as The Lancet, Cell, Tetrahedron and the
Discovery Today journals. With ScienceDirect, the r
searching and linking functionality, a
The rapid growth of the ScienceDirect collection is
publications and the ongoing addition to the Ba
disciplines. The latest step in this ambitious proje
volume one, issue one, is the addition of the h
ScienceDirect. Also available online for the first t
containing more than 12,000 articles that highlight
life scien
For more information, visit
www.sciencedirect.com77 Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for
immunologic self-tolerance and negative control of immune responses.
Annu. Rev. Immunol. 22, 531–562
78 Coombes, J.L. et al. (2005) Regulatory T cells and intestinal
homeostasis. Immunol. Rev. 204, 184–194
79 Oak, J.S. et al. (2006) Sjogren’s syndrome-like disease in mice with T
cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci.
U. S. A. 103, 16882–16887
80 Wilson, B.S. et al. (2002) FceRI signaling observed from the inside of
the mast cell membrane. Mol. Immunol. 38, 1259–1268
81 Tkaczyk, C. et al. (2003) The phospholipase Cg1-dependent pathway of
FceRI-mediated mast cell activation is regulated independently of
phosphatidylinositol 3-kinase. J. Biol. Chem. 278, 48474–48484
82 Furumoto, Y. et al. (2006) Cutting edge: lentiviral short hairpin RNA
silencing of PTEN in humanmast cells reveals constitutive signals that
promote cytokine secretion and cell survival. J. Immunol. 176, 5167–
5171
83 Rivera, J. and Gilfillan, A.M. (2006) Molecular regulation of mast cell
activation. J. Allergy Clin. Immunol. 117, 1214–1225
84 Kitaura, J. et al. (2000) Akt-dependent cytokine production in mast
cells. J. Exp. Med. 192, 729–740
85 Lee, J.S. et al. (2005) Phosphatidylinositol (3,4,5)-trisphosphate
specifically interacts with the phox homology domain of phospholipase
D1 and stimulates its activity. J. Cell Sci. 118, 4405–4413
86 Peng, Z. and Beaven, M.A. (2005) An essential role for phospholipase D
in the activation of protein kinase C and degranulation in mast cells. J.
Immunol. 174, 5201–5208
87 Okada, T. et al. (2000) BCAP: the tyrosine kinase substrate that
connects B cell receptor to phosphoinositide 3-kinase activation.
Immunity 13, 817–827
88 Itoh, S. et al. (2002) Adapter molecule Grb2-associated binder 1 is
specifically expressed inmarginal zone B cells and negatively regulates
thymus-independent antigen-2 responses. J. Immunol. 168, 5110–
5116
89 Wang, Y. et al. (2005) Single and combined deletions of the NTAL/LAB
and LAT adaptors minimally affect B-cell development and function.
Mol. Cell. Biol. 25, 4455–4465
90 Wood, J.E. et al. (2006) TcR and TcR-CD28 engagement of protein
kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates
independently of guanine nucleotide exchange factor VAV-1. J. Biol.
Chem. 281, 32385–32394
91 Reynolds, L.F. et al. (2002) Vav1 transduces T cell receptor signals to
the activation of phospholipase C-g1 via phosphoinositide 3-kinase-
dependent and -independent pathways. J. Exp. Med. 195, 1103–1114
92 Barber, D.F. et al. (2006) Class IB-phosphatidylinositol 3-kinase (PI3K)
deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell
invasion. J. Immunol. 176, 589–593
93 Deane J.A. et al.T cell function is partiallymaintained in the absence of
class IA phosphoinositide 3-kinase signaling Blood (in press)ct collection
ction covers more than 1900 journals, including
full suite of Trends, Current Opinion and Drug
esearch process is enhanced with unsurpassed
ll on a single, intuitive interface.
a result of the integration of several prestigious
ckfiles – heritage collections in a number of
ct to digitize all of Elsevier’s journals back to
ighly cited Cell Press journal collection on
ime are six Cell titles’ long-awaited Backfiles,
important historic developments in the field of
ces.
www.sciencedirect.com
